AveXis Inc.

(AVXS)

By |

Profile

AveXis Inc is a clinical-stage gene therapy company. It is engaged in developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its product candidate is AVXS-101.

Contact Information

Website: www.avexis.com
Main Phone: +1 847 572-8280
Address: 2275 Half Day Road
Address 2: Suite 160
State: IL
City / Town: Bannockburn
Country: USA
Postal Code: 60015

Issuer Information

Exchange: NGS
Employees: 18
NAICS: Pharmaceutical P
$ 55.64 ($ 1.25) (-2.20%)
Last Price 55.64 Change $ -1.25 Change % -2.20 Tick N/A
Bid 54.60 Bid Size 200.00 Ask 500.00 Ask Size 100.00
Open 56.65 High 57.23 Low 55.13 Prev Close 56.89
Last Trade Volume 267,252 52 Wk Hi 72.73 52 Wk Low 16.11
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 27,676,288.00 EPS (TTM) -2.75 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 15
Number of Buys 0 8
Number of Sells 0 7
Net Activity 0 105000
Last 10 Buys Shares
Bong Y. Koh 1,000
Andrew F. Knudten 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 60 60 60 65
Low Target Price Estimate 42 42 42 42
Mean Target Price Estimate 51 51 51 53.5
Standard Deviation 12.73 12.73 12.73 16.26
Date of Most Recent Estimate 08/12/16 06/22/16 06/22/16 08/23/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 1 2
Moderate Buy 0 0 0 0
Hold 0 2 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 2.33 2 1